181 related articles for article (PubMed ID: 15205117)
21. Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon.
Cheng Y; Tauschel HD; Nilsson A; Duan RD
Scand J Gastroenterol; 1999 Sep; 34(9):915-20. PubMed ID: 10522612
[TBL] [Abstract][Full Text] [Related]
22. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A
Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142
[TBL] [Abstract][Full Text] [Related]
23. Alkaline sphingomyelinase (NPP7) promotes cholesterol absorption by affecting sphingomyelin levels in the gut: A study with NPP7 knockout mice.
Zhang P; Chen Y; Cheng Y; Hertervig E; Ohlsson L; Nilsson A; Duan RD
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G903-8. PubMed ID: 24650549
[TBL] [Abstract][Full Text] [Related]
24. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.
Liu F; Cheng Y; Wu J; Tauschel HD; Duan RD
Cancer Lett; 2006 Apr; 235(1):141-6. PubMed ID: 16290921
[TBL] [Abstract][Full Text] [Related]
25. Effects of fat, beef and fiber in diets on activities of sphingomyelinase, ceramidase and caspase-3 in rat colonic mucosa.
Yang L; Mutanen M; Cheng Y; Duan RD
Med Princ Pract; 2002; 11(3):150-6. PubMed ID: 12138298
[TBL] [Abstract][Full Text] [Related]
26. Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.
Chen Y; Xu SC; Duan RD
Lipids Health Dis; 2015 Oct; 14():130. PubMed ID: 26493087
[TBL] [Abstract][Full Text] [Related]
27. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
[TBL] [Abstract][Full Text] [Related]
28. Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.
Cheng Y; Liu F; Wu J; Zhang Y; Nilsson A; Duan RD
Lipids; 2009 Oct; 44(10):897-906. PubMed ID: 19777283
[TBL] [Abstract][Full Text] [Related]
29. Alkaline lipase in rat intestinal mucosa: physiological parameters.
Rao RH; Mansbach CM
Arch Biochem Biophys; 1993 Aug; 304(2):483-9. PubMed ID: 8346923
[TBL] [Abstract][Full Text] [Related]
30. Understanding the molecular activity of alkaline sphingomyelinase (NPP7) by computer modeling.
Duan J; Wu J; Cheng Y; Duan RD
Biochemistry; 2010 Oct; 49(42):9096-105. PubMed ID: 20839774
[TBL] [Abstract][Full Text] [Related]
31. Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model.
Andersson D; Kotarsky K; Wu J; Agace W; Duan RD
Dig Dis Sci; 2009 Jul; 54(7):1440-8. PubMed ID: 18989780
[TBL] [Abstract][Full Text] [Related]
32. Ursolic acid inhibits acid sphingomyelinase in intestinal cells.
Zhang P; Cheng Y; Duan RD
Phytother Res; 2013 Feb; 27(2):173-8. PubMed ID: 22511398
[TBL] [Abstract][Full Text] [Related]
33. Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice.
Zhang Y; Cheng Y; Hansen GH; Niels-Christiansen LL; Koentgen F; Ohlsson L; Nilsson A; Duan RD
J Lipid Res; 2011 Apr; 52(4):771-81. PubMed ID: 21177474
[TBL] [Abstract][Full Text] [Related]
34. Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity.
Duan RD; Nilsson A
Hepatology; 1997 Oct; 26(4):823-30. PubMed ID: 9328299
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of lipopolysaccharide-induced release of interleukin-8 from intestinal epithelial cells by SMA, a novel inhibitor of sphingomyelinase and its therapeutic effect on dextran sulphate sodium-induced colitis in mice.
Sakata A; Yasuda K; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Soeda S
Cell Immunol; 2007 Jan; 245(1):24-31. PubMed ID: 17466962
[TBL] [Abstract][Full Text] [Related]
36. Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer.
Di Marzio L; Di Leo A; Cinque B; Fanini D; Agnifili A; Berloco P; Linsalata M; Lorusso D; Barone M; De Simone C; Cifone MG
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):856-62. PubMed ID: 15824156
[TBL] [Abstract][Full Text] [Related]
37. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S
Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462
[TBL] [Abstract][Full Text] [Related]
38. Effects of phospholipids on sphingomyelin hydrolysis induced by intestinal alkaline sphingomyelinase: an in vitro study.
Liu JJ; Nilsson A; Duan RD
J Nutr Biochem; 2000 Apr; 11(4):192-7. PubMed ID: 10827341
[TBL] [Abstract][Full Text] [Related]
39. Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: a potential implication in tumorigenesis.
Duan RD; Cheng Y; Tauschel HD; Nilsson A
Dig Dis Sci; 1998 Jan; 43(1):26-32. PubMed ID: 9508530
[TBL] [Abstract][Full Text] [Related]
40. Entamoeba histolytica: soluble and membrane-associated neutral sphingomyelinase-C and other unidentified esterase activity.
Vargas-Villarreal J; Palacios-Corona R; Hernández-Luna C; Mata-Cárdenas BD; Torres de la Cruz VM; Cortés-Gutiérrez EI; González-Salazar F; Garza-González JN; Escobedo-Guajardo BL; Said-Fernández S
Exp Parasitol; 2010 Aug; 125(4):394-9. PubMed ID: 20350542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
